Riskpilot← Back to searchSign inGet full accessWILLIAM MED S AS
ASActiveOrg 914097770Ruseløkkveien 6, 0251 OsloRental and operating of own or leased real estate · NACE 6820Est. 20140 employees
Revenue 2025
NOK 180K
+33% vs 2024
EBITDA margin
76.4%
+38% vs 2024
Equity ratio
29.2%
Financial strength
Net profit 2025
NOK 6K
+176% vs 2024
| Revenue | NOK 180K | +33% |
| EBITDA | NOK 138K | +38% |
| Net profit | NOK 6K | +176% |
| Total assets | NOK 3,2M | +0% |
| Equity | NOK 948K | +1% |
| Employees | 0 | — |
Legal name
WILLIAM MED S AS
Org number
914097770
Legal form
Aksjeselskap
NACE code
6820 · Rental and operating of own or leased real estate
Founded
30. september 2014
Share capital
NOK 945 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Handel, investering i fast eiendom og verdipapirer samt annen virksomhet i tilknytning til dette, herunder deltagelse i andre selskaper med tilsvarende virksomhet gjennom egenkapital, lån eller ved avgivelse av garantier, og andre produkter/tjenester som naturlig hører sammen med dette.
Address
Ruseløkkveien 6, 0251 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 135 | 180 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | 0 | 0 | 0 | 99 | 138 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 0 | 0 | 0 | 99 | 138 |
| Net financials | 0 | 0 | 4 | −108 | −131 |
| Profit before tax | 0 | 0 | 4 | −8 | 6 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 0 | 0 | 4 | −8 | 6 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 945 | 945 | 950 | 3 241 | 3 246 |
| Equity | 945 | 945 | 950 | 941 | 948 |
| Long-term debt | 0 | 0 | 0 | 1 825 | 1 727 |
| Short-term debt | 0 | 0 | 0 | 475 | 571 |
| Total debt | 0 | 0 | 0 | 2 300 | 2 299 |
EBITDA margin
76.4%
This company
15.8%
Market median
+384% vs market
20212025
Equity ratio
29.2%
This company
38.2%
Market median
-24% vs market
20212025
Return on equity
0.7%
This company
18.4%
Market median
-96% vs market
20212025
Net profit margin
3.5%
This company
8.1%
Market median
-57% vs market
20212025
Asset turnover
0.06×
This company
1.12×
Market median
-95% vs market
20212025
Debt / equity
2.43×
This company
0.62×
Market median
-292% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 33.33% | 33.33% | 2022 | |
| Company | 33.33% | 33.33% | 2022 | |
| Individual | 33.33% | 33.33% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Williams Investments As
WILLIAM MED S AS Board members of WILLIAM MED S AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| William Andre Vallestad | Chairman | 0 companies |
| Kristoffer Knudsen | Board of Directors | 0 companies |
| Kenneth Williams | Board of Directors | 0 companies |